Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53
about
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathwayStimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirusHuman herpesvirus 8--a novel human pathogenViral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative actionThe IRF family, revisitedUse of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysisKaposi's Sarcoma Herpesvirus Genome PersistenceKSHV-Mediated Angiogenesis in Tumor ProgressionKSHV: pathways to tumorigenesis and persistent infectionMolecular virology of Kaposi's sarcoma-associated herpesvirusAzidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 FunctionAngiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated HerpesvirusKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.Murine gamma-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrestViral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesKSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation.Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Viral latency and its regulation: lessons from the gamma-herpesviruses.Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.Contribution of viral mimics of cellular genes to KSHV infection and disease.Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCRThe Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoterKSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivatorImmune evasion by Kaposi's sarcoma-associated herpesvirus.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3betaMolecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis
P2860
Q24316207-5C87F108-6B11-4A98-B215-F6D1EDCAD961Q24338664-178A7C85-5378-438F-B446-344BC1931807Q24530670-CE5FAB82-AD1D-4DCA-A2DB-C153006CAB35Q24538223-CA28FD79-6A61-4AD8-A68A-9F259309E20AQ24672548-0A0906BC-993E-4FDF-A97E-259A70680308Q24678497-60C91391-5BEE-46D4-83FC-CC57E2F7419AQ24799552-CA579357-1D67-4FC9-B753-7B7593D32906Q26738483-FAF833C3-22B8-455C-91E9-771D8D8126DDQ26742030-27584B13-ED98-4A74-9D34-701025991CE4Q27026000-D096B545-0059-477D-9352-FEA4973C1378Q28363323-04DC1B7D-6734-45F4-92D4-D73E49D82A5EQ28554487-AC38CBFB-B324-479E-961E-09C236AF64FDQ28750291-99D3B384-0D64-4979-8013-16886E5E8A28Q29394711-6CAEDC2B-AC93-439F-AA50-E5E8E8A6AF6CQ30311122-BEE8AAB8-3358-4BF3-91B2-23597C0B5AE7Q33223011-6D38389E-DC59-483A-9069-A5C384C4621EQ33560572-879FCF6A-CC50-4A64-BFEB-5CC86F1AF6BBQ33598569-E0F1A643-CAED-41BA-B4BF-5ED9CA228211Q33623056-B02AB569-6E6A-4199-BF8B-10394175154EQ33748042-18D96DEA-84A6-4DEE-B686-B71D66B6097EQ33761091-34BCF762-436D-4879-AB27-4740AE533D57Q33826818-8AE13208-CAE6-4398-B618-C33CE6A86949Q33842636-5B65D960-81C6-4664-8467-4CF17A7D93DAQ33906970-021FF23A-1333-4B16-9106-EF332563A775Q33955300-6204544F-784C-409A-A6D3-6E1E3F26AA59Q34013830-2D8C23DA-8EED-434B-B718-8BDA5F624A2BQ34039189-4DA39559-4EF0-473E-9B8F-DC1F5448471BQ34124015-333DB2D1-1D96-4966-94AF-735F2B188944Q34192731-268772DC-826A-4C22-8509-513F43DCA9CAQ34299388-C2648D43-8364-40DE-95F1-DA2C648310F1Q34303583-92551AD0-8184-4D9C-920C-2C473EFD2B59Q34340317-F1FECFAB-4395-4F49-B53E-5FAC6FC30A2EQ34359380-91A01221-30B8-41B6-A746-F7B2A9A2FB0BQ34423454-1B75F6B4-D1C0-454C-88EB-F71E157E7AE5Q34615002-26C37238-155D-418E-826A-12103ED010F3Q34782463-D4F043C1-7FB1-49F7-B0A6-927BEC8AEE68Q34795543-A1AFD1D3-C946-44FC-9461-91C48F469A4EQ35026060-8871CD11-1122-475A-978C-2D20091FC16EQ35104781-9283FB72-BE25-43BC-9F16-3A6AA581A8E6Q35124404-DDA6C43E-67E6-4ED0-9FCA-6CD557E8DE83
P2860
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@ast
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@en
type
label
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@ast
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@en
prefLabel
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@ast
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@en
P2860
P50
P1433
P1476
Kaposi's sarcoma-associated he ...... iral protein that inhibits p53
@en
P2093
A E Thlick
C Parravicini
P2860
P304
P356
10.1128/JVI.75.1.429-438.2001
P577
2001-01-01T00:00:00Z